Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DSM, Crucell License PER.C6 To Masterclone | Contract Pharma

What are you searching for?

Sign in
Breaking News

DSM, Crucell License PER.C6 To Masterclone

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

DSM and Crucell entered a non-exclusive PER.C6 research licensing agreement with Russia-based Masterclone. Masterclone will use Crucell’s technology to develop an undisclosed antibody. Financial details were not disclosed.

The PER.C6 technology platform has been developed for the large-scale manufacture of biopharmaceutical products such as vaccines and proteins.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters